Kyriakis E., Solovou T.G.A., Kun S., Czifrák K., Szőcs B., Juhász L., Bokor É., Stravodimos G.A., Kantsadi A.L., Chatzileontiadou D.S.M., Skamnaki V.T., Somsák L., Leonidas D.D. (2018)
Human liver glycogen phosphorylase (hlGP), a key enzyme in glycogen metabolism, is a valid pharmaceutical target for the development of new anti-hyperglycaemic agents for type 2 diabetes. Inhibitor discovery studies have ...